1. Home
  2. BFH vs AMLX Comparison

BFH vs AMLX Comparison

Compare BFH & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bread Financial Holdings Inc.

BFH

Bread Financial Holdings Inc.

N/A

Current Price

$106.88

Market Cap

3.8B

ML Signal

N/A

Logo Amylyx Pharmaceuticals Inc.

AMLX

Amylyx Pharmaceuticals Inc.

N/A

Current Price

$28.07

Market Cap

3.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BFH
AMLX
Founded
1996
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.8B
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
BFH
AMLX
Price
$106.88
$28.07
Analyst Decision
Buy
Strong Buy
Analyst Count
17
12
Target Price
★ $114.81
$42.64
AVG Volume (30 Days)
489.3K
★ 1.3M
Earning Date
10-22-2026
11-13-2026
Dividend Yield
★ 0.97%
N/A
EPS Growth
★ 98.36
65.46
EPS
★ 11.54
N/A
Revenue
★ $4,521,400,000.00
$380,786,000.00
Revenue This Year
$4.67
N/A
Revenue Next Year
$3.23
N/A
P/E Ratio
$8.93
★ N/A
Revenue Growth
N/A
★ 1612.94
52 Week Low
$59.26
$10.83
52 Week High
$114.53
$41.14

Technical Indicators

Market Signals
Indicator
BFH
AMLX
Relative Strength Index (RSI) 58.61 47.96
Support Level $107.24 $26.16
Resistance Level $110.26 $28.60
Average True Range (ATR) 3.24 1.34
MACD 0.63 0.21
Stochastic Oscillator 87.60 51.58

Price Performance

Historical Comparison
BFH
AMLX

About BFH Bread Financial Holdings Inc.

Formed by a combination of JCPenney's credit card processing unit and The Limited's credit card bank business, Bread Financial is a provider of private-label and co-branded credit cards, loyalty programs, and marketing services. The company's most financially significant unit is its credit card business, which partners with retailers to jointly market Bread's credit cards to their customers. The company also retains a minority interest in spun-off LoyaltyOne, which operates the largest airline miles loyalty program in Canada and offers marketing services to grocery chains in Europe and Asia.

About AMLX Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.

Share on Social Networks: